Emergent Biosolutions Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +6.1% | -22.9% | -13.8% | +48.3% | +29.7% | -39.2% | +86.9% | -21.2% | +55.9% | -29.6% | +27.6% | +28.2% | +7.8% | -42.7% | +105.0% | -2.4% | +51.3% | -41.2% | +15.9% | -17.2% | +119.8% | -57.5% | -22.0% | +0.0% | +37.8% | -50.3% | +105.7% | -19.9% | +2.3% | +8.6% | -15.2% | +15.4% | -33.7% | +14.1% | -36.6% | +64.0% | -35.7% | +5.0% | +50.1% | – | |
| – | -2.1% | +1.6% | -9.4% | +10.1% | +27.2% | -1.1% | +31.9% | -3.4% | +52.8% | -15.1% | +19.4% | -2.0% | -17.7% | -10.4% | +49.3% | +15.0% | +11.3% | -33.7% | +83.6% | -3.8% | +11.0% | -31.7% | +9.5% | -14.5% | -11.4% | +12.7% | +13.7% | -17.0% | -39.7% | +48.6% | +100.6% | -59.5% | -55.1% | +81.6% | -21.1% | +22.3% | +0.1% | -13.3% | +9.7% | – | |
| – | +13.3% | -41.5% | -19.5% | +104.9% | +31.7% | -68.6% | +220.3% | -38.9% | +60.9% | -51.3% | +49.0% | +91.6% | +35.2% | -63.9% | +195.2% | -16.7% | +96.7% | -45.9% | -37.2% | -48.0% | +580.9% | -75.3% | -82.0% | +168.9% | +219.8% | -114.9% | – | -25.1% | +83.1% | -16.8% | -146.5% | – | -16.9% | -14.7% | -50.6% | +124.5% | -63.9% | +45.1% | +103.0% | – | |
| – | -0.3% | -24.5% | +25.8% | -12.0% | +25.8% | +2.1% | -15.1% | +49.8% | +40.5% | -11.3% | +38.6% | -16.4% | +17.6% | -32.0% | +12.2% | +76.2% | -29.5% | -11.8% | -6.9% | +1.4% | +67.3% | -44.1% | +13.6% | -19.9% | +36.5% | -29.3% | -36.1% | -41.2% | +92.2% | -48.6% | +116.6% | -57.8% | -34.1% | +67.0% | -14.5% | +3.8% | -10.4% | -13.2% | -12.4% | – | |
| – | +206.3% | -71.8% | -9.3% | +8.3% | +194.2% | -60.4% | -1.7% | +6.6% | +189.3% | -46.3% | +8.3% | -8.2% | +209.5% | -65.4% | +9.0% | -0.7% | +93.0% | -45.1% | +14.0% | -10.0% | +14.5% | -9.8% | -4.4% | -1.1% | +17.5% | +6.7% | -9.1% | -5.9% | +4.3% | -5.6% | +1.4% | -10.8% | -20.6% | -13.8% | -16.6% | -11.0% | +31.4% | -8.8% | -4.3% | – | |
| – | -13.1% | +0.5% | -9.8% | +10.4% | +59.4% | -22.2% | -1.1% | +6.0% | +111.1% | -17.7% | +7.0% | -6.8% | +57.7% | -32.3% | +6.9% | +31.3% | -18.4% | -0.6% | +9.7% | -8.3% | +54.1% | -33.9% | -4.5% | +1.7% | +137.0% | -46.0% | +237.6% | -19.6% | -36.3% | -52.6% | +36.6% | -27.8% | +46.4% | -53.5% | -16.1% | -8.2% | +20.8% | -9.7% | +359.4% | – | |
| – | +43.6% | -70.7% | -42.8% | +460.1% | +11.1% | -117.9% | – | -68.1% | -47.4% | -342.9% | – | – | +9.9% | -114.9% | – | -51.3% | +321.0% | -63.0% | -84.8% | -339.3% | – | -97.7% | -1,284.4% | – | – | – | – | – | – | – | -611.3% | – | -114.7% | – | -99.0% | +15,260.0% | -121.6% | – | -1,291.4% | – | |
| – | +23.7% | -23.6% | -6.9% | +10.3% | -57.0% | -72.7% | +330.8% | -36.3% | +1,146.1% | +20.0% | -1.0% | +8.4% | -11.7% | -5.5% | -25.6% | +18.8% | +14.5% | -2.3% | +1.2% | -2.3% | +7.1% | -8.9% | -4.9% | +9.0% | +50.6% | +39.8% | +59.8% | -31.1% | +12.7% | +9.5% | -2.9% | -64.8% | +78.3% | -0.7% | +0.0% | +3.4% | -3.3% | -25.2% | -9.1% | – | |
| – | +46.4% | -72.2% | -50.7% | +589.1% | +12.1% | -118.1% | – | -67.3% | -83.7% | -1,180.0% | – | – | +21.4% | -129.8% | – | -54.4% | +359.6% | -66.3% | -91.5% | -731.9% | – | -101.4% | – | – | – | – | – | – | – | – | -2,329.8% | – | -119.4% | – | -118.1% | – | -188.0% | – | -1,341.0% | – | |
| – | +27.9% | -81.2% | -33.4% | +506.3% | +40.8% | -125.0% | – | -96.2% | +1,066.7% | -268.6% | – | – | +56.7% | -135.8% | – | -44.6% | +334.8% | -77.0% | -83.2% | -592.3% | – | -100.1% | – | – | -15.6% | +52.4% | -56.3% | -122.3% | – | – | +329.0% | +107.5% | -86.6% | +567.6% | -119.4% | – | -39.1% | +69.2% | +110.6% | – | |
| – | +75.2% | -72.0% | -56.0% | +626.8% | +1.2% | -114.4% | – | -58.3% | -116.7% | – | – | – | +8.6% | -126.7% | – | -57.4% | +369.4% | -62.4% | -93.4% | -810.9% | – | -102.0% | – | – | – | – | – | – | – | – | -3,245.6% | – | -127.3% | – | -117.6% | – | -206.6% | – | -2,750.0% | – | |
| – | +34.9% | -61.9% | -26.8% | +213.3% | +23.6% | -96.1% | +2,728.6% | -57.4% | +30.3% | -102.7% | – | +369.2% | +11.2% | -85.2% | +854.0% | -23.2% | +142.5% | -56.7% | -61.7% | -105.3% | – | -89.5% | -221.2% | – | – | – | – | -51.5% | -157.9% | – | -307.4% | – | -78.5% | +535.2% | -83.6% | +341.1% | -112.9% | – | -422.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.